PL2066314T3 - Zastosowanie teogaliny do leczenia umysłowych zaburzeń zdolności do koncentracji, depresji i demencji - Google Patents

Zastosowanie teogaliny do leczenia umysłowych zaburzeń zdolności do koncentracji, depresji i demencji

Info

Publication number
PL2066314T3
PL2066314T3 PL07818393T PL07818393T PL2066314T3 PL 2066314 T3 PL2066314 T3 PL 2066314T3 PL 07818393 T PL07818393 T PL 07818393T PL 07818393 T PL07818393 T PL 07818393T PL 2066314 T3 PL2066314 T3 PL 2066314T3
Authority
PL
Poland
Prior art keywords
theogallin
dementia
depression
treatment
mental concentration
Prior art date
Application number
PL07818393T
Other languages
English (en)
Polish (pl)
Inventor
Adolf Kler
Reinhold Zenger
Wilfried Dimpfel
Original Assignee
Plantextrakt Gmbh&Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantextrakt Gmbh&Co Kg filed Critical Plantextrakt Gmbh&Co Kg
Publication of PL2066314T3 publication Critical patent/PL2066314T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL07818393T 2006-09-26 2007-09-25 Zastosowanie teogaliny do leczenia umysłowych zaburzeń zdolności do koncentracji, depresji i demencji PL2066314T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006045764A DE102006045764A1 (de) 2006-09-26 2006-09-26 Verwendung von Theogallin zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Erkrankungen des zentralen Nervensystems, insbesondere von mentalen Konzentrationsleistungsstörungen, Depression und Demenz
PCT/EP2007/008308 WO2008037416A2 (de) 2006-09-26 2007-09-25 Verwendung von theogallin zur behandlung von mentalen konzentrationsleistungsstörungen, drepression und demenz
EP07818393.6A EP2066314B1 (de) 2006-09-26 2007-09-25 Verwendung von theogallin zur behandlung von mentalen konzentrationsleistungsstörungen, depression und demenz

Publications (1)

Publication Number Publication Date
PL2066314T3 true PL2066314T3 (pl) 2014-05-30

Family

ID=39134217

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07818393T PL2066314T3 (pl) 2006-09-26 2007-09-25 Zastosowanie teogaliny do leczenia umysłowych zaburzeń zdolności do koncentracji, depresji i demencji

Country Status (5)

Country Link
EP (1) EP2066314B1 (de)
DE (1) DE102006045764A1 (de)
ES (1) ES2443222T3 (de)
PL (1) PL2066314T3 (de)
WO (1) WO2008037416A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200000581A1 (it) * 2022-01-17 2023-07-17 Univ Degli Studi Di Verona Acido chinico per l'uso nel trattamento dei disturbi dell'umore - Quinic acid for use in the treatment of mood disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8496914B2 (en) * 2005-12-13 2013-07-30 Richard Paul Bonfiglio Antibacterial oral rinse formulation for preventing coronary artery disease

Also Published As

Publication number Publication date
WO2008037416A3 (de) 2008-06-12
WO2008037416A2 (de) 2008-04-03
EP2066314A2 (de) 2009-06-10
DE102006045764A1 (de) 2008-04-03
EP2066314B1 (de) 2013-12-04
ES2443222T3 (es) 2014-02-18

Similar Documents

Publication Publication Date Title
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
AP2011005672A0 (en) Pyrazolopyrimidines and their use for the treatment of CNS disorders.
IL195819A0 (en) Modulators of metabolism and the treatment of disorders related thereto
IL195851A0 (en) Modulators of metabolism and the treatment of disorders related thereto
ZA200806114B (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
HK1115341A1 (en) Composition for treating mental health disorders
EP2064319A4 (de) Verfahren zur erzeugung von glia- und neuronalen zellen und verwendung davon für die behandlung medizinischer leiden des zns
EP2278972A4 (de) Behandlung für neurologische und psychische erkrankungen
PL2982372T3 (pl) Środki modulujące stężenie glutaminianu stosowane w leczeniu zaburzeń psychicznych
ZA200901523B (en) Use of extracts for the treatment of viral disorders
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
IL193697A0 (en) Methods for treating cognitive and other disorders
IL188390A0 (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
IL200570A0 (en) Combination therapy, composition and methods for the treatment of cardiovascular disorders
IL197766A0 (en) Use of oritavancin for the prevention and treatment of anthrax
IL198134A (en) A combination of antipsychotic drugs and tetracyclines to treat psychiatric illnesses
ZA200709443B (en) Methods for the treatment of substance abuse and dependence
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
PL2066314T3 (pl) Zastosowanie teogaliny do leczenia umysłowych zaburzeń zdolności do koncentracji, depresji i demencji
IL198479A0 (en) Methods for screening for therapeutic molecules and use of the molecules therefrom
ZA200800409B (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
GB0517214D0 (en) Kit and method for detecting the risk of certain mental disorders
GB0616708D0 (en) Kit and method for detecting the risk of certain mental disorders